Professional Documents
Culture Documents
Hemodialysis Catheter-Related Infection: Jafar Alsaid, M.B.CH.B, Md. Fasn. Facp. 2021 1
Hemodialysis Catheter-Related Infection: Jafar Alsaid, M.B.CH.B, Md. Fasn. Facp. 2021 1
infection
Transplant
PD
Home HD
257
111
7
8
Vascular access use at initiation and on day
of eligibility, 2011.
USRD
50% S2013
USRD
S
2013
HD catheter
USRDS
2020
70%
USRDS 2020
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 12
USRDS 2020
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 13
92%
Ishani A, Collins AJ, Herzog CA, Foley RN: Septicemia, access and cardiovascular disease in dialysis patients: The
USRDS Wave 2 study. Kidney Int 68: 311–318, 2005
Gauge.
Length.
Luminal design.
Material.
Tip design.
Antiseptic impregnated.
Higher risks:
Immunosuppressed patients.
S. Alb < 3.5g/dl.
Beathard GA, Urbanes A: Infection associated with tunneled hemodialysis catheters. Semin dial 21: 528–538, 2008.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 20
DURATION
25% by 1 month.
50% by 2 months.
Agarwal, Anil K, Asif Arif. NephSAP. Interventional Nephrology, ASN. 361-375. 2009.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 22
Recommended duration for HD catheters:
Vascath:
IJ 2-3wks?
Subclavian 2-3wks?
Femoral. 2-5days?
Cuffed tunneled:
1 year –Indefinite.
2. Site of insertion.
4. Non Dm.
Fry AC, Stratton J, Farrington K, Mahna K, Selvakumar S, Thompson T, Warwicker P: Factors affecting long-term survival of tunneled
haemodialysis catheters: A prospective audit of 812 tunneled catheters. Nephrol Dial Transplant 23: 275–281, 2008
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 24
Catheter
Location
Inflammatory signs:
2. Tunnel Infection.
Agarwal, Anil K, Asif Arif. NephSAP. Interventional Nephrology, ASN. 361-375. 2009.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 32
Hemodialysis catheter infection
Rate of uncuffed cath. infection:
8% by 2wks.
25% by 1 month.
50% by 2 months.
Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 35
practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-S164.
Definition of Exit Site infection
• Erythema.
• Purulent Discharge.
Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 36
practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-S164.
Exit site infection
• Obtain Cx.
Agarwal, Anil K, Asif Arif. NephSAP. Interventional Nephrology, ASN. 361-375. 2009.
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 37
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 38
Catheter Tunnel infection
• Inflammatory signs over the tunnel.
• Purulent discharge.
• IV AB.
• Different site.
Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical practice guideline
for vascular access: 2019JAFAR
update.
ALSAID, Am J Kidney
M.B.CH.B, MD. FASN. Dis. 2020;75(4)(suppl 2):S1-S164.
FACP. 2021 40
Catheter related Bacteremia
Clinical picture:
Fever with chills.
No other focus.
Sepsis.
Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical practice
guideline for vascular access:
JAFAR ALSAID, 2019 update.
M.B.CH.B, MD. FASN.Am
FACP.J2021
Kidney Dis. 2020;75(4)(suppl 2):S1-S164. 42
Definition of Central Venous Catheter Blood stream infection
Clinical symptoms.
Catheter (Hub or tip Cx.) >15 CFU/cath. seg. or > 100 /Cath semiquantitative
2 hours interval.
Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 45
practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-
Strict Infection Control Protocol.
Can it work?
Nurses' catheter
care
Infection Control
Protocol
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 48
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 49
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 50
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 51
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 52
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 53
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 54
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 55
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 56
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 57
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 58
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 59
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 60
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 61
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 62
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 63
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 64
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 65
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 66
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 67
BSH Hemodialysis population,
over 112 months. Jan.
% 2004 – May. 2013
AVF 20%
Access types:
AVG 18%
Cuffed
56%
cath.
N= 147 patients.
Vascath. 6% 8741 HD
AVF AVG VC PC
1200
1000
800
600
400
200
0
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
72
ASN Poster
76
Hemodialysis Blood steam infection at BSH
Jan. 2004 - Sep. 2019
0.025
International data 0.75-4.4
0.02 0.02
/100 patient month
0.015
0.01
0.007
0.004
0.005
0.003
0
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
77
Year
Admission for Hemodialysis related blood stream infection per 1000 patient-year
0.9
0.79 International rate 108
0.8 0.73
/ 1000 patient Year
0.68
0.7
0.6
0.5
0.4 0.4
0.3
0.2
0.1
0
2011 2015 2017 2019
Years 78
Catheter Salvage in poor access
30% AB treatment could clear infection.
Exchange:
72 hours post AB.
No need for negative blood Cx.
National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice
recommendations for vascular access 2006. Am J Kidney Dis 48[Suppl 1]: S176–S322, 2006
Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G: Comparison of tissue plasminogen activator–
antibiotic locks with heparin–antibiotic locks in children with catheter-related bacteraemia. Nephrol Dial Transplant 23:
2604–2610, 2008.
Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE: Treatment of long-term intravascular catheter-
related bacteremia with antibiotic lock: Randomized, placebo-controlled trial. J Antimicrob Chemother 55: 90–94, 2005
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 80
Antibiotic locking solutions
Concentration: 5mg/ml.
Maya ID, Carlton D, Estrada E, Allon M: Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with antibiotic lock: A
quality improvement report. Am J Kidney Dis 50: 289–295,2007
JAFAR ALSAID, M.B.CH.B, MD. FASN. FACP. 2021 82
Different AB surface coating catheters
Results:
Less likely to exchange with early AB lock.
Infection recurrence within 45 days was similar.
Infection free survival of catheter was longer for early
AB lock.
Onder AM, Chandar J, Billings AA, Simon N, Diaz R, Francoeur D, Abitbol C,
Zilleruelo G: Comparison of early versus late use of antibiotic locks in the treatment
JAFAR
of catheter-related ALSAID, M.B.CH.B,
bacteremia. ClinMD. FASN.
J Am SocFACP. 2021
Nephrol 3: 1048–1056, 2008 84
Antibiotic Lock
RCT.
18 children.
24 episodes of Catheter related Bacteremia.
Randomized to Heparin or rtPA AB lock.
Endocarditis.
Septic arthritis.